276 related articles for article (PubMed ID: 31248638)
1. Time-intensity-curve Analysis and Tumor Extravasation of Nanobubble Ultrasound Contrast Agents.
Wu H; Abenojar EC; Perera R; De Leon AC; An T; Exner AA
Ultrasound Med Biol; 2019 Sep; 45(9):2502-2514. PubMed ID: 31248638
[TBL] [Abstract][Full Text] [Related]
2. Acoustic characterization and pharmacokinetic analyses of new nanobubble ultrasound contrast agents.
Wu H; Rognin NG; Krupka TM; Solorio L; Yoshiara H; Guenette G; Sanders C; Kamiyama N; Exner AA
Ultrasound Med Biol; 2013 Nov; 39(11):2137-46. PubMed ID: 23932272
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound molecular imaging of ovarian cancer with CA-125 targeted nanobubble contrast agents.
Gao Y; Hernandez C; Yuan HX; Lilly J; Kota P; Zhou H; Wu H; Exner AA
Nanomedicine; 2017 Oct; 13(7):2159-2168. PubMed ID: 28603079
[TBL] [Abstract][Full Text] [Related]
4. Nanobubble ultrasound contrast agents for enhanced delivery of thermal sensitizer to tumors undergoing radiofrequency ablation.
Perera RH; Solorio L; Wu H; Gangolli M; Silverman E; Hernandez C; Peiris PM; Broome AM; Exner AA
Pharm Res; 2014 Jun; 31(6):1407-17. PubMed ID: 23943542
[TBL] [Abstract][Full Text] [Related]
5. Formulation and characterization of echogenic lipid-Pluronic nanobubbles.
Krupka TM; Solorio L; Wilson RE; Wu H; Azar N; Exner AA
Mol Pharm; 2010 Feb; 7(1):49-59. PubMed ID: 19957968
[TBL] [Abstract][Full Text] [Related]
6. Improving performance of nanoscale ultrasound contrast agents using N,N-diethylacrylamide stabilization.
Perera RH; Wu H; Peiris P; Hernandez C; Burke A; Zhang H; Exner AA
Nanomedicine; 2017 Jan; 13(1):59-67. PubMed ID: 27565686
[TBL] [Abstract][Full Text] [Related]
7. Effect of Bubble Concentration on the in Vitro and in Vivo Performance of Highly Stable Lipid Shell-Stabilized Micro- and Nanoscale Ultrasound Contrast Agents.
Abenojar EC; Nittayacharn P; de Leon AC; Perera R; Wang Y; Bederman I; Exner AA
Langmuir; 2019 Aug; 35(31):10192-10202. PubMed ID: 30913884
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-Based Molecular Imaging of Tumors with PTPmu Biomarker-Targeted Nanobubble Contrast Agents.
Johansen ML; Perera R; Abenojar E; Wang X; Vincent J; Exner AA; Brady-Kalnay SM
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671448
[TBL] [Abstract][Full Text] [Related]
9. Nanobubbles are Non-Echogenic for Fundamental-Mode Contrast-Enhanced Ultrasound Imaging.
Myers JZ; Navarro-Becerra JA; Borden MA
Bioconjug Chem; 2022 Jun; 33(6):1106-1113. PubMed ID: 35476906
[TBL] [Abstract][Full Text] [Related]
10. Cyanine 5.5 conjugated nanobubbles as a tumor selective contrast agent for dual ultrasound-fluorescence imaging in a mouse model.
Mai L; Yao A; Li J; Wei Q; Yuchi M; He X; Ding M; Zhou Q
PLoS One; 2013; 8(4):e61224. PubMed ID: 23637799
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous Intravital Optical and Acoustic Monitoring of Ultrasound-Triggered Nanobubble Generation and Extravasation.
Pellow C; O'Reilly MA; Hynynen K; Zheng G; Goertz DE
Nano Lett; 2020 Jun; 20(6):4512-4519. PubMed ID: 32374617
[TBL] [Abstract][Full Text] [Related]
12. Role of Surface Tension in Gas Nanobubble Stability Under Ultrasound.
Hernandez C; Nieves L; de Leon AC; Advincula R; Exner AA
ACS Appl Mater Interfaces; 2018 Mar; 10(12):9949-9956. PubMed ID: 29494124
[TBL] [Abstract][Full Text] [Related]
13. Production and characterization of a novel long-acting Herceptin-targeted nanobubble contrast agent specific for Her-2-positive breast cancers.
Jiang Q; Hao S; Xiao X; Yao J; Ou B; Zhao Z; Liu F; Pan X; Luo B; Zhi H
Breast Cancer; 2016 May; 23(3):445-55. PubMed ID: 25691133
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy.
Rapoport N; Gao Z; Kennedy A
J Natl Cancer Inst; 2007 Jul; 99(14):1095-106. PubMed ID: 17623798
[TBL] [Abstract][Full Text] [Related]
15. A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature.
Warram JM; Sorace AG; Saini R; Umphrey HR; Zinn KR; Hoyt K
J Ultrasound Med; 2011 Jul; 30(7):921-31. PubMed ID: 21705725
[TBL] [Abstract][Full Text] [Related]
16. The Optimized Fabrication of Nanobubbles as Ultrasound Contrast Agents for Tumor Imaging.
Cai WB; Yang HL; Zhang J; Yin JK; Yang YL; Yuan LJ; Zhang L; Duan YY
Sci Rep; 2015 Sep; 5():13725. PubMed ID: 26333917
[TBL] [Abstract][Full Text] [Related]
17. Low frequency nanobubble-enhanced ultrasound mechanotherapy for noninvasive cancer surgery.
Bismuth M; Katz S; Mano T; Aronovich R; Hershkovitz D; Exner AA; Ilovitsh T
Nanoscale; 2022 Sep; 14(37):13614-13627. PubMed ID: 36070492
[TBL] [Abstract][Full Text] [Related]
18. Construction of Nucleolin-Targeted Lipid Nanobubbles and Contrast-Enhanced Ultrasound Molecular Imaging in Triple-Negative Breast Cancer.
Fang K; Wang L; Huang H; Lan M; Shen D; Dong S; Guo Y
Pharm Res; 2020 Jul; 37(7):145. PubMed ID: 32666304
[TBL] [Abstract][Full Text] [Related]
19. Concurrent visual and acoustic tracking of passive and active delivery of nanobubbles to tumors.
Pellow C; Abenojar EC; Exner AA; Zheng G; Goertz DE
Theranostics; 2020; 10(25):11690-11706. PubMed ID: 33052241
[No Abstract] [Full Text] [Related]
20. Evaluation of the potential of doxorubicin loaded microbubbles as a theranostic modality using a murine tumor model.
Abdalkader R; Kawakami S; Unga J; Suzuki R; Maruyama K; Yamashita F; Hashida M
Acta Biomater; 2015 Jun; 19():112-8. PubMed ID: 25795624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
